ATE439829T1 - Gel oder lísung enthaltend dihydrotestosterone, deren herstellungsverfahren und verwendung - Google Patents

Gel oder lísung enthaltend dihydrotestosterone, deren herstellungsverfahren und verwendung

Info

Publication number
ATE439829T1
ATE439829T1 AT01403166T AT01403166T ATE439829T1 AT E439829 T1 ATE439829 T1 AT E439829T1 AT 01403166 T AT01403166 T AT 01403166T AT 01403166 T AT01403166 T AT 01403166T AT E439829 T1 ATE439829 T1 AT E439829T1
Authority
AT
Austria
Prior art keywords
dht
gel
production
solution containing
dihydrotestosterone
Prior art date
Application number
AT01403166T
Other languages
English (en)
Inventor
Valerie Masini-Eteve
Brigitte Taravella
Original Assignee
Besins Int Belgique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Besins Int Belgique filed Critical Besins Int Belgique
Application granted granted Critical
Publication of ATE439829T1 publication Critical patent/ATE439829T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Prostheses (AREA)
AT01403166T 2001-12-07 2001-12-07 Gel oder lísung enthaltend dihydrotestosterone, deren herstellungsverfahren und verwendung ATE439829T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01403166A EP1317921B1 (de) 2001-12-07 2001-12-07 Gel oder Lösung enthaltend Dihydrotestosterone, deren Herstellungsverfahren und Verwendung

Publications (1)

Publication Number Publication Date
ATE439829T1 true ATE439829T1 (de) 2009-09-15

Family

ID=8183007

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01403166T ATE439829T1 (de) 2001-12-07 2001-12-07 Gel oder lísung enthaltend dihydrotestosterone, deren herstellungsverfahren und verwendung

Country Status (12)

Country Link
US (1) US20030087885A1 (de)
EP (1) EP1317921B1 (de)
AT (1) ATE439829T1 (de)
AU (1) AU2002364625A1 (de)
CA (1) CA2469028C (de)
CY (1) CY1110602T1 (de)
DE (1) DE60139625D1 (de)
DK (1) DK1317921T3 (de)
ES (1) ES2330188T3 (de)
MX (1) MXPA04005517A (de)
PT (1) PT1317921E (de)
WO (1) WO2003047548A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
HRP20030510A2 (en) * 2000-12-22 2005-04-30 Dr. August Wolff Gmbh & Co. Arzneimittel Gel composition and trans-scrotal application of acomposition for the treatment of hypogonadism
US20040072810A1 (en) * 2001-11-07 2004-04-15 Besins International Belgique Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof
EP1572178B1 (de) * 2002-12-18 2006-05-03 Laboratoires Besins International Behandlung von mastalgie mit4-hydroxy-tamoxifen
EP2050443B1 (de) * 2002-12-18 2017-05-24 Besins Healthcare Luxembourg SARL Verringerung der dichte des brustgewebes durch 4-hydroxy tamoxifen
CA2519980C (en) * 2003-04-01 2012-04-10 Laboratoires Besins International Prevention and treatment of breast cancer with 4-hydroxy tamoxifen
DE602004013439T2 (de) * 2003-06-09 2009-06-04 Ascend Therapeutics, Inc. Behandlung und prävention von übermässiger narbenbildung mit 4-hydroxy tamoxifen
US20050037040A1 (en) * 2003-08-13 2005-02-17 Moshe Arkin Topical compositions of urea and ammonium lactate
US20050042182A1 (en) * 2003-08-13 2005-02-24 Moshe Arkin Topical compositions of urea
US20050036953A1 (en) * 2003-08-13 2005-02-17 Moshe Arkin Topical compositions of ammonium lactate
JP2007531694A (ja) * 2003-07-11 2007-11-08 マクロケム・コーポレーション 局所適用医薬組成物
US20050042268A1 (en) * 2003-07-16 2005-02-24 Chaim Aschkenasy Pharmaceutical composition and method for transdermal drug delivery
US20050020552A1 (en) * 2003-07-16 2005-01-27 Chaim Aschkenasy Pharmaceutical composition and method for transdermal drug delivery
US20050025833A1 (en) * 2003-07-16 2005-02-03 Chaim Aschkenasy Pharmaceutical composition and method for transdermal drug delivery
CA2549824C (en) * 2003-12-15 2012-03-13 Laboratoires Besins International Use of 4-hydroxytamoxifen for the preparation of a medicament for the treatment of gynecomastia
US7968532B2 (en) * 2003-12-15 2011-06-28 Besins Healthcare Luxembourg Treatment of gynecomastia with 4-hydroxy tamoxifen
EP1550440A1 (de) * 2003-12-15 2005-07-06 Laboratoires Besins International Verwendung von 4-hydroxytamoxifen zur Herstellung eines Arzneimittels zur Behandlung von Gynäkomastie
US7507769B2 (en) * 2004-03-22 2009-03-24 Laboratoires Besins International Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen
EP1579856A1 (de) * 2004-03-22 2005-09-28 Laboratoires Besins International 4-Hydroxytamoxifen zur Behandlung von benignen Brusterkrankungen
AU2005227072B2 (en) * 2004-03-22 2010-08-19 Besins Healthcare Luxembourg Sarl Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen
US20050208139A1 (en) * 2004-03-22 2005-09-22 Ascend Therapeutics, Inc. Chemically stable compositions of 4-hydroxy tamoxifen
EP1634583A1 (de) 2004-09-09 2006-03-15 Laboratoires Besins International Testosterongele enthaltend Propylenglykol als Resorptionsverstärker
JP2008512425A (ja) * 2004-09-09 2008-04-24 ラボラトワール ブザン アンテルナスィヨナル 透過促進剤としてのプロピレングリコールを含むテストステロンゲル
KR20080016552A (ko) * 2005-04-13 2008-02-21 유니메드 파마슈티칼스, 인크. 여성의 테스토스테론 및 관련된 스테로이드의 농도를증가시키는 방법
RS52671B (sr) 2005-10-12 2013-06-28 Unimed Pharmaceuticals Llc Poboljšani gel testosterona i postupak korišćenja
AU2012200290B2 (en) * 2005-10-19 2014-08-21 Havah Therapeutics Pty Ltd Reduction of side effects from aromatase inhibitors used for treating breast cancer
CA2626337C (en) * 2005-10-19 2015-12-29 Chavah Pty Ltd Reduction of side effects from aromatase inhibitors used for treating breast cancer
CA2878841C (en) * 2011-07-14 2021-01-26 Elyptol Pty. Ltd. Disinfecting formulations and uses thereof
CA2965372C (en) 2014-10-22 2023-09-05 Havah Therapeutics Pty Ltd Methods of reducing mammographic breast density and/or breast cancer risk
CA3002562A1 (en) 2015-10-22 2017-04-27 Havah Therapeutics Pty Ltd Methods of reducing mammographic breast density and/or breast cancer risk
CN109276539A (zh) * 2018-11-08 2019-01-29 北京海霞润月更年期综合症医学研究院 一种睾酮凝胶及制备方法
CN114599369B (zh) 2019-06-03 2026-02-10 哈瓦赫治疗有限公司 用于递送雄激素剂和芳香酶抑制剂的药物制剂和系统以及使用方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2519252A1 (fr) 1982-01-07 1983-07-08 Besins Jean Medicament a base de dihydrotestosterone pour le traitement des deficits des secretions androgeniques testiculaires
US5152997A (en) * 1990-12-11 1992-10-06 Theratech, Inc. Method and device for transdermally administering testosterone across nonscrotal skin at therapeutically effective levels
EP0952833A1 (de) * 1996-05-02 1999-11-03 Azupharma GmbH Topische penile androgen-applikation zur behandlung der erektilen dysfunktion
US6562369B2 (en) * 1999-12-16 2003-05-13 Dermatrends, Inc. Transdermal administration of androgenic drugs hydroxide-releasing agents as permeation enhancers

Also Published As

Publication number Publication date
WO2003047548A1 (fr) 2003-06-12
DK1317921T3 (da) 2009-12-21
EP1317921A1 (de) 2003-06-11
DE60139625D1 (de) 2009-10-01
ES2330188T3 (es) 2009-12-07
CA2469028A1 (fr) 2003-06-12
CY1110602T1 (el) 2015-04-29
EP1317921B1 (de) 2009-08-19
PT1317921E (pt) 2009-11-06
MXPA04005517A (es) 2005-03-23
US20030087885A1 (en) 2003-05-08
AU2002364625A1 (en) 2003-06-17
CA2469028C (fr) 2012-08-14

Similar Documents

Publication Publication Date Title
DE60139625D1 (de) Gel oder Lösung enthaltend Dihydrotestosterone, deren Herstellungsverfahren und Verwendung
DE69739856D1 (de) Agonisten für den rezeptor des hepatozyten-wachstumsfaktors und deren anwendungen
HU9201329D0 (en) The use of sulphonamides for medical purpose and process for the production of new sulphonamides
DK0433225T3 (da) Fremgangsmåde til fremstilling af biologisk aktivt protein, f.eks. TGF
ATE312103T1 (de) Substituierte porphyrine und deren therapeutische verwendungen
BR0007781A (pt) Conjugado fisiologicamente ativo, composição, e, processo para a produção de um conjugado de peg-gcsf
BRPI0415398A (pt) composto, composição farmacêutica, processo para a preparação da mesma, uso de um composto, método de tratamento de cáncer, e, processo para preparação de um composto
BR0209777A (pt) Formulações lìquidas estáveis
SE8102193L (sv) Terapeutiskt aktiv organisk forening och dess anvendning
ATE235459T1 (de) Derivate von aminosäuren, sie enthaltende pharmazeutische zusammensetzungen sowie deren herstellunsgverfahren
DK15589D0 (da) Kemiske forbindelser
ATE509004T1 (de) 3-alkylierte 5,5',6,6',7,7',8,8'-octahydro-2, 2'binaphthole und 3,3'-dialkylierte 5,5',6,6',7, 7',8,8'-octahydro-2,2'-binaphthole sowie herstellungsverfahren dafür
ATE293595T1 (de) Thyroidhormon-analoga und verfahren zu ihrer herstellung
ATE306934T1 (de) Von willenbrand faktor (vwf) enthaltende zubereitung, verfahren zür herstellung von vwf enthaltenden zubereitungen und deren verwendung
WO2003087049A3 (de) Arzneimittelkombinationen enthaltend heterocyclische verbindungen und ein neues anticholinergikum
DE59608422D1 (de) Verfahren zur Herstellung von Poly(diorganosiloxanen), Mischungen, enthaltend diese Poly(diorganosiloxane) und deren Verwendung
DE69533043D1 (de) Acrylamid-derivate und verfahren zu deren herstellung
HUT54988A (en) Process for producing substituted n-(quinolin-2-ylmethoxy)-benzylsulfonylureas and pharmaceutical compositions comprising such compounds
HUT57205A (en) Process for producing cycloalkano/b/-indol derivatives and pharmaceutical compositions containing them
ES2059457T3 (es) Utilizacion de bezafibrato para el tratamiento de la diabetes.
ATE85623T1 (de) Fibrin(ogen) derivate, verfahren zu ihrer herstellung und ihre vewendung.
BRPI0415497A (pt) composto processo para a sua preparação , composição farmacêutica que compreende o mesmo, utilização de um composto e método para o tratamento de diabetes do tipo ii
PT83929B (pt) Processo de preparacao de 3-benzazepinas substituidas por sulfinilo e sulfonilo e das composicoes farmaceuticas que as contem
ATE153032T1 (de) Zyklische angiopeptin derivate, deren herstellung und pharmazeutische zusammensetzungen
ATE80625T1 (de) 2-benzimidazolylalkylthio(oder sulfinyl- oder sulfonyl)-derivate, verfahren zu deren herstellung und deren anwendung als arzneimittel.

Legal Events

Date Code Title Description
EEFA Change of the company name
UEP Publication of translation of european patent specification

Ref document number: 1317921

Country of ref document: EP